Filing Details
- Accession Number:
- 0000899243-19-012052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-03 17:26:48
- Reporting Period:
- 2019-05-01
- Accepted Time:
- 2019-05-03 17:26:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408498 | L David Lowrance | 6836 Bee Cave Road, Building Iii Suite 200 Austin TX 78746 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-01 | 3,800 | $1.51 | 3,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-01 | 3,800 | $10.76 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-02 | 3,700 | $1.51 | 3,700 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-02 | 3,700 | $10.82 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-05-01 | 3,800 | $0.00 | 3,800 | $1.51 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-05-02 | 3,700 | $0.00 | 3,700 | $1.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 84,384 | 2026-10-25 | No | 4 | M | Direct | |
| 80,684 | 2026-10-25 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 26, 2018.
- The price is a weighted average sale price. The sale prices ranged from $10.55 to $11.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price is a weighted average sale price. The sale prices ranged from $10.68 to $11.02. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The shares subject to the option vest and become exercisable in sixteen equal installments on each quarterly anniversary of October 25, 2016, subject to the reporting person's continued service with Savara Inc.
Billionaire Hedge Funds
